Boston Biotechnology Summit ®

BRIDGE TO COLLABORATION

The Third Annual Boston Biotechnology Summit, was held at Philadelphia’s renowned Wistar Institute on Sunday June 2, 2019! A very successful Event with Europe and America’s best minds, leaders from Biotech, Medtech, Ehealth, Pharma, Academia and Investors.


About The Event

  • Now in its 3rd year!
  • One day of effortless networking around curated content
  • Expanding this year to include more leaders from across Europe
  • The best place to meet Boston’s biotechnology elite

Boston Biotechnology Summit® is designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities and regional clusters, institutional, philanthropic and strategic investors. The Summit team is passionate about bringing the professionals together to spark new ideas and projects leading to improvement of patients’ health and well-being, globally. 

The Summit in 3 years

The central theme of the first edition in 2017 was an introduction to the biotechnology ecosystems in Boston and Paris, which were also highlighted in terms of innovation and leadership.

The Summit®’s framework for its 2018 edition was “from the promise of raising capital to the reality of clinical trials” and featured speakers from the academic, biotech, investor, legal/regulatory and pharma worlds. A CEO “pitching session” was introduced.

The objective of the third Summit in 2019 held at The Wistar Institute was to further ensure that it could offer an efficient and cost-effective forum which will add value for the companies taking part. To achieve this, the organizers’ aim was to maintain a rich content and a “human size” and to strategically expand this US-based Summit® to broader European participation. An International Program Committee was also set up.

Founded in 1892 as the first independent nonprofit biomedical research institute in the United States, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. Wistar’s business development team is advancing Wistar science and technology development through creative partnerships. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. wistar.org.

Our Sponsors

We’re proud to present this year’s Boston Biotechnology Summit® sponsors:

Become a Sponsor

Is your organization interested in becoming a sponsor for this year’s event?  Learn more about the sponsorship levels we offer to interested organizations and how to become a sponsor of the Boston Biotechnology Summit®. Find out which sponsorship level works best for your organization.

What Our Attendees Are Saying..

Here are what some of our past attendees have said about our annual event:

"The content is wonderful and the Organization is excellent. I have enjoyed connecting with the fantastic stakeholders and look forward to future collaborations throughout the next week and years" Retsina Meyer, PhD, Neuroscientist - Entrepreneur - Innovator, Cambridge MA, USA. 2017 & 2018 attendee.
"The Boston Paris Biotechnology Summit gathers the most advanced and emerging biotech and venture capital pioneers from Paris and Boston and allows attendees to learn from their wealth of knowledge. The agenda is well curated to include scientific presentations as well as lectures on funding, regulatory and legal strategies making this the premier meeting for learning how to establish a biotech company in the US. This conference is a “must attend” for founders, scientists and funders alike." Vanessa Elharrar, MD, Fmr., Director of Therapeutic Research, National Institutes of Health (NIH) Office of the Director. Medical Director, PPD, Maryland, USA.
"I have participated in the Boston Biotechnology Summit® twice, already !! My company is GENOSKIN and our mission is to provide the cosmetic, chemical and pharmaceutical industry with the next generation of human skin models and assays for dermatological testing. In the 2017 Summit, in Paris, France, we presented Genoskin products and data at the Poster Session. In the 2018 Boston Summit, I was one of the six CEOs selected to pitch to a panel of Academic Experts, Investors and Pharma/Bio Executives. Genoskin has expanded its activities by opening an office in Salem MA, USA. Pascal Descargues, PhD, Chief Executive Officer, Genoskin, Toulouse France & Salem MA."